CytomX Therapeutics

CTMX • NASDAQ • Stock Fundamentals

CytomX Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sean A. McCarthy, with a market cap of $648.8M.

Market Cap$648.8M

Employees122.0

CEOSean A. McCarthy

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about CytomX Therapeutics

CytomX Therapeutics (CTMX) has a market capitalization of $648.8M and trades on NASDAQ.

CytomX Therapeutics has approximately 122 employees.